Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?

The Canadian Journal of Psychiatry- Volume 66, Issue 2
2021
Philip G. Tibbo, MD, FRCPC Kyle A. McKee, MSc Jeffrey H. Meyer, MD, PhD, FRCPC Candice E. Crocker, MSc, PhD Katherine J. Aitchison, BM, BCH, PhD, FRCPsych Raymond W. Lam, MD, FRCPC David N. Crockford, MD, FRCPC

Abstract

A position statement developed by the Canadian Psychiatric Association’s (CPA) Research Committee and approved by the CPA’s Board of Directors on May 13, 2020.
Open Full Article

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.

Search the Research Library

  • Conditions

  • Research Keywords

  • Search Text

  • Reset